Australia - English - Department of Health (Therapeutic Goods Administration)

smith & nephew pty ltd - silver sulfadiazine, quantity: 10 mg/g - cream - excipient ingredients: polysorbate 60; polysorbate 80; cetyl alcohol; propylene glycol; liquid paraffin; purified water; glyceryl monostearate - flamazine cream is indicated for the prevention of infection in severe burns. other types of wounds, such as pressure sores and leg ulcers, may also benefit from the application of flamazine cream.

Australia - English - Department of Health (Therapeutic Goods Administration)

smith & nephew pty ltd - silver sulfadiazine, quantity: 10 mg/g - cream - excipient ingredients: polysorbate 60; polysorbate 80; cetyl alcohol; propylene glycol; liquid paraffin; purified water; glyceryl monostearate - flamazine cream is indicated for the prevention of infection in severe burns. other types of wounds, such as pressure sores and leg ulcers, may also benefit from the application of flamazine cream.

Australia - English - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - metronidazole, quantity: 7.5 mg/g - cream - excipient ingredients: benzyl alcohol; isopropyl palmitate; glycerol; sorbitol solution (70 per cent) (non-crystallising); emulsifying wax; lactic acid; purified water - rozex cream is indicated for the treatment of inflammatory papules and pustules of rosacea.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - pimecrolimus, quantity: 10 mg/g - cream - excipient ingredients: sodium hydroxide; citric acid; benzyl alcohol; sodium cetostearyl sulfate; mono- and di- glycerides; cetyl alcohol; stearyl alcohol; propylene glycol; oleyl alcohol; medium chain triglycerides; purified water - elidel 1% cream is indicated for patients 3 months of age and older with atopic dermatitis (eczema) for: short term treatment of signs and symptoms; intermittent long-term treatment of emerging and resolving lesions in atopic dermatitis where the use of a topical corticosteroid is not yet warranted, no longer needed, or is inadvisable (according to the usage restrictions in the respective topical corticosteroid product information).

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dermal laboratories ltd - dithranol - cutaneous cream - 20mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dermal laboratories ltd - dithranol - cutaneous cream - 10mg/1gram

Canada - English - Health Canada

kao canada inc. - avobenzone; octisalate; octocrylene - cream - 1.25%; 5%; 1.1% - avobenzone 1.25%; octisalate 5%; octocrylene 1.1% - sunscreen agents

Israel - English - Ministry of Health

a.m.i. medical technologies limited, israel - adapalene - cream - adapalene 0.1 %w/w - adapalene - adapalene - for the cutaneous treatment of acne vulgaris, where comedones, papules and postules predominate. acne of the face, chest or back is appropriate for treatment. the treatment is limited up to six months in adolescents over 12 years.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - clindamycin phosphate, quantity: 22.8 mg/g (equivalent: clindamycin, qty 20 mg/g) - cream - excipient ingredients: purified water; polysorbate 60; benzyl alcohol; stearic acid; cetyl esters wax; propylene glycol; liquid paraffin; sorbitan monostearate; cetostearyl alcohol - dalacin v cream 2% is indicated for the treatment of symptomatic bacterial vaginosis. note: for the purposes of this indication bacterial vaginosis is usually defined by positive results to at least three of the four following criteria: 1. vaginal discharge with ph > 4.5; 2. vaginal discharge demonstrating an amine ("fishy") odour with the addition of 10% potassium hydroxide; 3. vaginal discharge with "clue cells" on microscopy, and; 4. a gram stain consistent with a diagnosis of bacterial vaginosis (lactobacillus morphotype absent or markedly decreased; gardnerella morphotype predominant flora; white blood cells absent or few; mobiluncus morphotype may or may not be present). other pathogens which may be associated with genital infection such as trichomonas vaginalis, candida albicans, chlamydia trachomatis and neisseria gonorrhoeae should be ruled out by appropriate laboratory means.

Australia - English - Department of Health (Therapeutic Goods Administration)

glenmark pharmaceuticals australia pty ltd - mupirocin calcium, quantity: 21.5 mg/g - cream - excipient ingredients: cetomacrogol 1000; phenoxyethanol; purified water; liquid paraffin; glyceryl monostearate 40-55 per cent; benzyl alcohol; xanthan gum - supirocin (mupirocin) cream is indicated for the topical treatment of secondarily infected traumatic skin lesions such as small lacerations, sutured wounds or abrasions.